Cambodia vs Iraq: Hepatitis B surface antigen (HBsAg) prevalence
Cambodia
0.4%
in 2024
Iraq
0.4%
in 2024
Cambodia rank
62nd
Iraq rank
62nd
Hepatitis B surface antigen (HBsAg) prevalence over time
- Cambodia
- Iraq
How they compare
Cambodia currently reports 0.4% against 0.4% in Iraq, a difference of 0.0%.
Across all 10 years both countries report, Iraq has been ahead every year.
Cambodia ranks 62nd and Iraq ranks 62nd of 194 countries.
Iraq has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Cambodia | Iraq | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 0.4% | 0.8% | 0.4% | Iraq |
| 2020s | 0.4% | 0.5% | 0.1% | Iraq |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Cambodia or Iraq?
- Cambodia, at 0.4% against 0.4% in Iraq as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Cambodia and Iraq?
- 0.0%, with Cambodia ahead.
- How many years of comparable data are there for Cambodia and Iraq?
- 10 years are reported by both, from 2015 to 2024.
- How do Cambodia and Iraq rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Cambodia ranks 62nd and Iraq ranks 62nd of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.